Deposit of Biological Material – Impact on Validity of Priority Claim

Posted on March 1, 2013 by Warren Woessner

Please find linked below a guest post from Dr. Stefan Danner dealing with a new decision of the EPO Technical Boards of Appeal concerning the deposit of biological material.

Biotech IP Newsletter

This entry was posted in Int'l Practice and Policy and tagged Biotech IP Newsletter, biotechnology, biotechnology law, Dr. Steffan Danner, EPO, Warren Woessner. Bookmark the permalink.

← The Prometheus Factor – A Tech Transfer Adventure at AUTM

UK National Stem Cell Network Report – The Patent Watch Landscape →

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Comment *

Name *

Email *

Website

Save my name, email, and website in this browser for the next time I comment.

Search for:
Categories
Categories
Archives
Archives
Receive Email Updates
Certified Licensing Professionals, Inc., 2021
Disclaimer

This blog, Patents4Life, does not contain legal advice and is for informational purposes only. Its publication does not create an attorney-client relationship nor is it a solicitation for business. This is the personal blog of Warren Woessner and does not reflect the views of Schwegman Lundberg & Woessner, or any of its attorneys or staff. To the best of his ability, the Author provides current and accurate information at the time of each post, however, readers should check for current information and accuracy.
Search for: